'Some Hope Is Better Than Having No Hope'

'Some Hope Is Better Than Having No Hope'

The New York TimesThe New York Times

Up next

Health Trackers Are Everywhere. Do Babies Need Them, Too?

More and more people are wearing technology in the form of fitness bands and smart rings. These devices track metrics such as heart rate, skin temperature and sleep. The latest frontier is health tech for babies — and it’s being supercharged by artificial intelligence.Sapna Mahes ...  Show more

 . 34min 2sec
Trump Banned the Media. This Time, the Media Struck Back.

For every day of Donald J. Trump’s presidency, there has been a camera from a major television network pointed at him. But on Monday, that all changed.Zolan Kanno-Youngs and Michael M. Grynbaum discuss the face-off between the president and the press. Guest:Zolan Kanno-Youngs, a ...  Show more

 . 27min 39sec

Recommended Episodes

FDA Approves Aducanumab — A Controversial Drug For Alzheimer's
Short Wave

The FDA has approved a new drug for Alzheimer's. But a lot of experts are skeptical about whether the drug works. Rhitu Chatterjee talks with science correspondent Jon Hamilton about the controversial drug aducanumab and why the U.S. Food and Drug Administration approved it. For ...  Show more

 . 11min 52sec
How Well Does A New Alzheimer's Drug Work For Those Most At Risk?
Short Wave

A new drug for Alzheimer's disease, called lecanemab, got a lot of attention earlier this year for getting fast-tracked approval based on a clinical trial that included nearly 1,800 people. It was the most diverse trial for an Alzheimer's treatment to date, but still not enough t ...  Show more

 . 13min 46sec
Controversial new Alzheimer's drug in the spotlight
Business Daily

After decades without progress, this June a new treatment was approved by the US Food and Drugs Administration - Biogen's Aduhelm. Ivana Davidovic looks into why this process has been so controversial that is now under investigation by a federal watchdog.Aaron Kesselheim, a Harva ...  Show more

 . 18min 21sec
Why Aduhelm, a new Alzheimer's treatment, isn't reaching many patients
Short Wave

Aduhelm, known generically as aducanumab, is the first drug to actually affect the underlying disease process associated with Alzheimer's. Yet sales have been limited, and the drug is reaching very few patients — at least so far. It's expensive, risky and likely doing little to i ...  Show more

 . 9min 45sec